A recent study published in Infection Control and Hospital Epidemiology found that iodine-based skin preparation solutions, such as 3M's DuraPrep Surgical Solution, may be superior to chlorhexidine in preventing surgical-site infections. The study of over 3,200 general surgery patients suggests a significant reduction in morbidity and ...
Two pivotal Phase 3 trials evaluating HZT 501 met primary endpoints, showing a statistically significant reduction in gastrointestinal ulcers compared to ibuprofen alone. The treatment also demonstrated good tolerability and was well-received by patients.
Takeda's investigational PPI TAK-390MR demonstrates higher healing rates than lansoprazole among patients with more severe grades of erosive esophagitis. The drug combines dexlansoprazole with a Dual Delayed Release formulation, designed to provide extended duration of acid suppression.
TAK-390MR demonstrates consistently high healing rates and symptom relief for patients with erosive esophagitis, outperforming lansoprazole in phase 3 studies. The study's results showed that TAK-390MR produced significantly higher overall healing rates than lansoprazole across two studies.
New data on 3M's Tegaderm CHG shows it significantly suppresses skin flora regrowth, with superior prevention of flora regrowth on prepped skin compared to transparent dressings and BIOPATCH.
The collaboration aims to promote best practices in sterilization monitoring and provide objective educational resources to customers. Belimed will offer access to 3M's Attest Sterile U Network educational resources, while both companies advance higher standards of practice in sterile processing areas.
The International Association for the Study of Pain (IASP) has declared 2008 as the Global Year Against Pain in Women, highlighting the suffering caused by disparities in pain recognition and treatment. The campaign aims to increase awareness, empower women to seek proper treatment, and improve access to healthcare services.
A new survey of 2,082 nurses found that more than a quarter suffered from insomnia, with significant effects on medication dispensing errors, charting deviations, and falling asleep at work. Despite the impact, only 30% sought professional care to address their insomnia.